MMTV	B-OG
-	O
Wnt1	B-GP
and	O
-	O
ΔN89β	O
-	O
Catenin	O
Induce	O
Canonical	O
Signaling	O
in	O
Distinct	O
Progenitors	O
and	O
Differentially	O
Activate	O
Hedgehog	B-GP
Signaling	O
within	O
Mammary	B-DS
Tumors	I-DS

Conceived	O
and	O
designed	O
the	O
experiments	O
:	O
PC	O
.	O

Performed	O
the	O
experiments	O
:	O
BT	O
AP	O
AI	O
SH	O
MH	O
.	O

Analyzed	O
the	O
data	O
:	O
BT	O
AP	O
AI	O
SH	O
PC	O
.	O

Wrote	O
the	O
paper	O
:	O
PC	O
.	O

Canonical	O
Wnt	B-GP
/	O
β	B-GP
-	I-GP
catenin	I-GP
signaling	O
regulates	O
stem	O
/	O
progenitor	O
cells	O
and	O
,	O
when	O
perturbed	O
,	O
induces	O
many	O
human	B-OG
cancers	B-DS
.	O

A	O
significant	O
proportion	O
of	O
human	B-OG
breast	B-DS
cancer	I-DS
is	O
associated	O
with	O
loss	O
of	O
secreted	O
Wnt	B-GP
antagonists	O
and	O
mice	B-OG
expressing	O
MMTV	B-OG
-	O
Wnt1	B-GP
and	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
develop	O
mammary	B-DS
adenocarcinomas	I-DS
.	O

Many	O
studies	O
have	O
assumed	O
these	O
mouse	B-OG
models	O
of	O
breast	B-DS
cancer	I-DS
to	O
be	O
equivalent	O
.	O

Here	O
we	O
show	O
that	O
MMTV	B-OG
-	O
Wnt1	B-GP
and	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
transgenes	O
induce	O
tumors	B-DS
with	O
different	O
phenotypes	O
.	O

Using	O
axin2	B-GP
/	O
conductin	B-GP
reporter	O
genes	O
we	O
show	O
that	O
MMTV	B-OG
-	O
Wnt1	B-GP
and	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
activate	O
canonical	O
Wnt	B-GP
signaling	O
within	O
distinct	O
cell	O
-	O
types	O
.	O
ΔN89β	O
-	O
catenin	O
activated	O
signaling	O
within	O
a	O
luminal	O
subpopulation	O
scattered	O
along	O
ducts	O
that	O
exhibited	O
a	O
K18	B-GP
+	O
ER	B-GP
−	O
PR	B-GP
−	O
CD24highCD49flow	O
profile	O
and	O
progenitor	O
properties	O
.	O

In	O
contrast	O
,	O
MMTV	B-OG
-	O
Wnt1	B-GP
induced	O
canonical	O
signaling	O
in	O
K14	B-GP
+	O
basal	O
cells	O
with	O
CD24	B-GP
/	O
CD49f	B-GP
profiles	O
characteristic	O
of	O
two	O
distinct	O
stem	O
/	O
progenitor	O
cell	O
-	O
types	O
.	O

MMTV	B-OG
-	O
Wnt1	B-GP
produced	O
additional	O
profound	O
effects	O
on	O
multiple	O
cell	O
-	O
types	O
that	O
correlated	O
with	O
focal	O
activation	O
of	O
the	O
Hedgehog	B-GP
pathway	O
.	O

We	O
document	O
that	O
large	O
melanocytic	B-DS
nevi	I-DS
are	O
a	O
hitherto	O
unreported	O
hallmark	O
of	O
early	O
hyperplastic	O
Wnt1	B-GP
glands	O
.	O

These	O
nevi	B-DS
formed	O
along	O
the	O
primary	O
mammary	O
ducts	O
and	O
were	O
associated	O
with	O
Hedgehog	B-GP
pathway	O
activity	O
within	O
a	O
subset	O
of	O
melanocytes	O
and	O
surrounding	O
stroma	O
.	O

Hh	B-GP
pathway	O
activity	O
also	O
occurred	O
within	O
tumor	B-DS
-	O
associated	O
stromal	O
and	O
K14	B-GP
+/	O
p63	B-GP
+	O
subpopulations	O
in	O
a	O
manner	O
correlated	O
with	O
Wnt1	B-GP
tumor	B-DS
onset	O
.	O

These	O
data	O
show	O
MMTV	B-OG
-	O
Wnt1	B-GP
and	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
induce	O
canonical	O
signaling	O
in	O
distinct	O
progenitors	O
and	O
that	O
Hedgehog	B-GP
pathway	O
activation	O
is	O
linked	O
to	O
melanocytic	B-DS
nevi	I-DS
and	O
mammary	B-DS
tumor	I-DS
onset	O
arising	O
from	O
excess	O
Wnt1	B-GP
ligand	O
.	O

They	O
further	O
suggest	O
that	O
Hedgehog	B-GP
pathway	O
activation	O
maybe	O
a	O
critical	O
component	O
and	O
useful	O
indicator	O
of	O
breast	B-DS
tumors	I-DS
arising	O
from	O
unopposed	O
Wnt1	B-GP
ligand	O
.	O

Introduction	O

Wnts	B-GP
are	O
a	O
family	O
of	O
secreted	O
proteins	O
that	O
regulate	O
tissue	O
patterning	O
and	O
homeostasis	O
.	O

The	O
canonical	O
Wnt	B-GP
pathway	O
operates	O
by	O
inhibiting	O
proteolysis	O
of	O
cytoplasmic	O
β	B-GP
-	I-GP
catenin	I-GP
,	O
which	O
enters	O
the	O
nucleus	O
and	O
regulates	O
transcription	O
through	O
Lef	B-GP
/	O
Tcf	B-GP
DNA	O
binding	O
partners	O
.	O

It	O
is	O
well	O
documented	O
that	O
canonical	O
Wnt	B-GP
/	O
β	B-GP
-	I-GP
catenin	I-GP
signaling	O
is	O
required	O
for	O
the	O
viability	O
of	O
particular	O
stem	O
cells	O
,	O
and	O
forced	O
activation	O
of	O
this	O
pathway	O
can	O
expand	O
stem	O
/	O
progenitors	O
,	O
alter	O
cell	O
fate	O
and	O
induce	O
tumorigenesis	O
[	O
1	O
]–[	O
3	O
].	O

Multiple	O
lines	O
of	O
evidence	O
demonstrate	O
roles	O
for	O
Wnt	B-GP
/	O
β	B-GP
-	I-GP
catenin	I-GP
signaling	O
in	O
mammary	O
development	O
and	O
breast	B-DS
cancer	I-DS
[	O
4	O
],	O
[	O
5	O
].	O

Multiple	O
Wnts	B-GP
are	O
expressed	O
throughout	O
mammary	O
development	O
.	O

Mice	B-OG
expressing	O
Wnt	B-GP
inhibitors	O
,	O
or	O
deficient	O
in	O
Lef	B-GP
-	I-GP
1	I-GP
,	O
show	O
defective	O
embryonic	O
mammary	O
development	O
,	O
and	O
loss	O
of	O
the	O
Wnt	B-GP
coreceptor	I-GP
,	O
LRP5	B-GP
/	O
6	O
,	O
impairs	O
postnatal	O
development	O
[	O
6	O
]–[	O
9	O
].	O

Both	O
loss	O
-	O
and	O
gain	O
-	O
of	O
-	O
function	O
studies	O
have	O
established	O
roles	O
for	O
Wnt4	B-GP
and	O
Wnt5a	B-GP
in	O
ductal	O
side	O
branching	O
and	O
for	O
β	B-GP
-	I-GP
catenin	I-GP
signaling	O
in	O
alveologenesis	O
and	O
survival	O
[	O
10	O
]–[	O
15	O
].	O

Although	O
β	B-GP
-	I-GP
catenin	I-GP
mutations	O
have	O
not	O
been	O
found	O
in	O
breast	B-DS
cancer	I-DS
,	O
pathway	O
activation	O
due	O
to	O
loss	O
of	O
the	O
extracellular	O
Wnt	B-GP
antagonist	O
,	O
sFRP1	B-GP
,	O
is	O
a	O
frequent	O
event	O
[	O
4	O
],	O
[	O
5	O
],	O
[	O
16	O
].	O

In	O
mice	B-OG
,	O
expression	O
of	O
Wnt1	B-GP
and	O
stabilized	O
β	B-GP
-	I-GP
catenin	I-GP
(	O
ΔN89β	O
-	O
catenin	O
)	O
under	O
the	O
control	O
of	O
the	O
mouse	B-OG
mammary	I-OG
tumor	I-OG
virus	I-OG
LTR	O
(	O
MMTV	B-OG
)	O
induces	O
precocious	O
mammary	O
development	O
and	O
adenocarcinoma	B-DS
formation	O
[	O
13	O
],	O
[	O
17	O
],	O
[	O
18	O
].	O

Tumors	B-DS
induced	O
by	O
both	O
transgenes	O
are	O
enriched	O
in	O
side	O
-	O
population	O
content	O
and	O
cells	O
expressing	O
primitive	O
cell	O
markers	O
that	O
exhibit	O
greater	O
colony	O
-	O
forming	O
capabilities	O
.	O

Collectively	O
,	O
these	O
studies	O
have	O
lead	O
to	O
the	O
hypothesis	O
that	O
canonical	O
Wnt	B-GP
/	O
β	B-GP
-	I-GP
catenin	I-GP
signaling	O
predisposes	O
mice	B-OG
to	O
breast	B-DS
cancer	I-DS
by	O
amplifying	O
stem	O
/	O
progenitor	O
populations	O
[	O
4	O
],	O
[	O
18	O
]–[	O
22	O
].	O

Recent	O
studies	O
have	O
shown	O
that	O
only	O
a	O
minor	O
subpopulation	O
of	O
human	B-OG
breast	B-DS
tumor	I-DS
cells	O
can	O
propagate	O
tumors	B-DS
[	O
23	O
].	O

Such	O
tumor	B-DS
-	O
initiating	O
cells	O
(	O
TICs	O
)	O
share	O
with	O
normal	O
stem	O
cells	O
the	O
ability	O
to	O
self	O
-	O
renew	O
and	O
to	O
generate	O
differentiated	O
progeny	O
.	O

Although	O
commonly	O
referred	O
to	O
as	O
cancer	B-DS
stem	O
cells	O
(	O
CSCs	O
),	O
it	O
is	O
unclear	O
whether	O
TICs	O
derive	O
from	O
stem	O
cells	O
and	O
/	O
or	O
from	O
less	O
potent	O
progeny	O
that	O
acquire	O
stem	O
cell	O
properties	O
during	O
transformation	O
.	O

Moreover	O
,	O
the	O
contribution	O
of	O
distinct	O
cancer	B-DS
stem	O
cells	O
to	O
breast	B-DS
cancer	I-DS
heterogeneity	O
remains	O
obscure	O
.	O

Candidate	O
mammary	O
stem	O
and	O
progenitor	O
populations	O
have	O
been	O
identified	O
by	O
ultrastructural	O
features	O
,	O
expression	O
of	O
stem	B-GP
cell	I-GP
antigen	I-GP
-	I-GP
1	I-GP
(	O
Sca	B-GP
-	I-GP
1	I-GP
),	O
and	O
ability	O
to	O
efflux	O
Hoechst	O
33342	O
dyes	O
,	O
which	O
upon	O
cell	O
sorting	O
generates	O
a	O
side	O
-	O
population	O
[	O
24	O
]–[	O
26	O
].	O

Recent	O
sorting	O
studies	O
of	O
murine	O
mammary	O
cells	O
have	O
identified	O
a	O
subpopulation	O
,	O
with	O
a	O
lineage	O
-	O
depleted	O
(	O
Lin	B-GP
−)/	O
CD24low	O
/	O
CD29	B-GP
/	O
49fhigh	O
/	O
Sca	B-GP
-	I-GP
1	I-GP
−/	O
keratin	B-GP
(	B-GP
K	I-GP
)	I-GP
14	I-GP
+	O
profile	O
,	O
that	O
are	O
enriched	O
in	O
“	O
mammary	O
repopulating	O
units	O
”	O
(	O
MRUs	O
),	O
which	O
have	O
a	O
parent	O
-	O
progeny	O
relationship	O
with	O
a	O
second	O
Lin	B-GP
−/	O
CD24high	O
/	O
CD29	B-GP
/	O
49flow	O
subpopulation	O
of	O
alveolar	O
-	O
limited	O
progenitors	O
expressing	O
a	O
predominantly	O
luminal	O
K18	B-GP
+	O
profile	O
[	O
21	O
],	O
[	O
27	O
].	O

Other	O
studies	O
have	O
described	O
luminal	O
progenitor	O
populations	O
with	O
CD24high	O
/	O
CD133	B-GP
−/	O
K18	B-GP
+	O
and	O
Lin	B-GP
−/	O
CD24	B-GP
+/	O
CD29low	O
/	O
CD61	B-GP
+	O
K14	B-GP
+	O
profiles	O
[	O
28	O
],	O
[	O
29	O
].	O

A	O
study	O
on	O
human	B-OG
breast	O
strongly	O
supports	O
the	O
concept	O
of	O
a	O
multipotent	O
stem	O
cell	O
located	O
within	O
a	O
ductal	O
luminal	O
niche	O
that	O
expresses	O
multiple	O
keratins	B-GP
[	O
30	O
].	O

Recently	O
the	O
connection	O
between	O
the	O
physiological	O
role	O
of	O
Wnt	B-GP
signaling	O
in	O
stem	O
cells	O
and	O
its	O
capacity	O
to	O
induce	O
cancer	B-DS
when	O
upregulated	O
has	O
been	O
exploited	O
to	O
identify	O
intestinal	O
stem	O
cells	O
by	O
virtue	O
of	O
their	O
expression	O
of	O
a	O
Wnt	B-GP
-	O
responsive	O
gene	O
,	O
Lgr5	B-GP
,	O
that	O
was	O
initially	O
found	O
to	O
be	O
upregulated	O
in	O
colonic	B-DS
tumors	I-DS
[	O
31	O
].	O

This	O
study	O
suggests	O
that	O
identifying	O
cell	O
-	O
types	O
that	O
respond	O
to	O
Wnt	B-GP
signaling	O
may	O
be	O
an	O
alternative	O
route	O
to	O
identify	O
and	O
illuminate	O
the	O
relationship	O
between	O
mammary	O
stem	O
/	O
progenitor	O
cells	O
and	O
cancer	B-DS
stem	O
cells	O
.	O

With	O
this	O
aim	O
in	O
mind	O
,	O
we	O
employed	O
Wnt	B-GP
-	O
responsive	O
conductin	B-GP
/	O
Axin2	B-GP
reporter	O
genes	O
to	O
identify	O
and	O
isolate	O
cells	O
showing	O
transcriptional	O
response	O
to	O
expression	O
of	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
and	O
MMTV	B-OG
-	O
Wnt1	B-GP
transgenes	O
.	O

Our	O
results	O
show	O
that	O
these	O
transgenes	O
lead	O
to	O
activation	O
of	O
the	O
canonical	O
Wnt	B-GP
pathway	O
in	O
distinct	O
cell	O
-	O
types	O
displaying	O
progenitor	O
and	O
stem	O
cell	O
characteristics	O
and	O
induce	O
tumors	B-DS
with	O
different	O
phenotypes	O
.	O

A	O
further	O
source	O
of	O
disparity	O
between	O
these	O
tumors	B-DS
arises	O
from	O
the	O
unique	O
ability	O
of	O
Wnt1	B-GP
to	O
influence	O
multiple	O
cells	O
types	O
within	O
the	O
gland	O
.	O

We	O
show	O
that	O
these	O
profound	O
effects	O
correlate	O
with	O
focal	O
induction	O
of	O
Hedgehog	B-GP
(	O
Hh	B-GP
)	O
pathway	O
activity	O
within	O
subpopulations	O
of	O
stromal	O
and	O
basal	O
(	O
K14	B-GP
+/	O
p63	B-GP
+)	O
cells	O
found	O
exclusively	O
within	O
the	O
Wnt	B-GP
-	I-GP
1	I-GP
tumor	B-DS
microenvironment	O
,	O
as	O
well	O
as	O
,	O
in	O
and	O
around	O
melanocytic	B-DS
hyperplastic	I-DS
nevi	I-DS
,	O
which	O
form	O
a	O
hallmark	O
of	O
all	O
MMTV	B-OG
-	O
Wnt1	B-GP
mammary	O
glands	O
.	O

These	O
data	O
show	O
that	O
Hh	B-GP
pathway	O
activation	O
is	O
linked	O
to	O
Wnt	B-GP
-	I-GP
1	I-GP
-	O
induced	O
mammary	B-DS
tumor	I-DS
onset	O
and	O
nevi	B-DS
formation	O
and	O
suggest	O
that	O
Hedgehog	B-GP
pathway	O
activation	O
maybe	O
a	O
critical	O
component	O
and	O
useful	O
marker	O
of	O
breast	B-DS
tumors	I-DS
arising	O
from	O
unopposed	O
Wnt1	B-GP
ligand	O
.	O

Results	O

MMTV	B-OG
-	O
Wnt1	B-GP
and	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
show	O
phenotypic	O
disparity	O

MMTV	B-OG
-	O
Wnt1	B-GP
and	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
induce	O
precocious	O
mammary	O
development	O
and	O
adenocarcinoma	B-DS
formation	O
[	O
13	O
],	O
[	O
17	O
].	O

However	O
,	O
the	O
two	O
types	O
of	O
transgenic	O
lines	O
differ	O
in	O
their	O
lactational	O
competence	O
[	O
13	O
],	O
[	O
17	O
].	O

This	O
functional	O
disparity	O
led	O
us	O
to	O
examine	O
the	O
respective	O
mammary	O
phenotypes	O
for	O
morphological	O
differences	O
that	O
may	O
yield	O
insight	O
into	O
the	O
corresponding	O
pathobiological	O
mechanisms	O
.	O

In	O
glands	O
expressing	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
acini	O
budded	O
directly	O
from	O
ductal	O
borders	O
(	O
Fig	O
.	O
1A	O
),	O
and	O
were	O
associated	O
with	O
spindle	O
-	O
shaped	O
K14	B-GP
+	O
basal	O
cells	O
(	O
Fig	O
.	O
1B	O
),	O
which	O
resembled	O
flattened	O
myoepithelial	O
cells	O
of	O
normal	O
alveoli	O
.	O

However	O
,	O
the	O
ducts	O
,	O
visualized	O
by	O
a	O
ductal	O
luminal	O
cell	O
marker	O
,	O
latent	B-GP
transforming	I-GP
growth	I-GP
factor	I-GP
-	I-GP
β	I-GP
-	I-GP
binding	I-GP
protein	I-GP
(	B-GP
LTBP	I-GP
)	I-GP
1	I-GP
-	O
lacZ	B-GP
(	O
Fig	O
.	O
1C	O
,	O
E	O
),	O
were	O
similar	O
to	O
those	O
of	O
controls	O
(	O
Fig	O
.	O
1D	O
).	O

In	O
contrast	O
,	O
MMTV	B-OG
-	O
Wnt1	B-GP
expression	O
induced	O
pronounced	O
ductal	O
changes	O
,	O
including	O
hyperbranching	O
(	O
Fig	O
.	O
1F	O
).	O

These	O
hyperplasias	O
were	O
encased	O
in	O
a	O
coherent	O
thick	O
K14	B-GP
+	O
cell	O
layer	O
(	O
Fig	O
.	O
1G	O
),	O
which	O
resembled	O
the	O
myoepithelial	O
layers	O
ensheathing	O
normal	O
ducts	O
.	O

Ductal	O
contortion	O
(	O
Fig	O
.	O
1H	O
),	O
cyst	O
formation	O
(	O
Fig	O
.	O
1I	O
),	O
and	O
lumenal	O
occlusions	O
(	O
Fig	O
.	O
1J	O
)	O
were	O
prominent	O
.	O

The	O
cellular	O
composition	O
and	O
architecture	O
of	O
the	O
tumors	B-DS
induced	O
by	O
the	O
transgenes	O
also	O
showed	O
subtle	O
but	O
important	O
differences	O
.	O

Tumors	B-DS
from	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
mice	B-OG
contained	O
many	O
more	O
K18	B-GP
+	O
than	O
K14	B-GP
+	O
cells	O
and	O
were	O
hormone	O
receptor	O
-	O
negative	O
(	O
Fig	O
.	O
2A	O
–	O
C	O
).	O

These	O
frequently	O
retained	O
well	O
-	O
differentiated	O
acinar	O
polarization	O
,	O
with	O
luminal	O
cells	O
expressing	O
apical	O
mucin	B-GP
(	B-GP
MUC	I-GP
)	I-GP
1	I-GP
(	O
Fig	O
.	O
2D	O
)	O
and	O
showing	O
basal	O
deposition	O
of	O
laminin	B-GP
V	I-GP
(	O
Fig	O
.	O
2E	O
).	O

Stromal	O
cells	O
,	O
detected	O
by	O
vimentin	B-GP
antibodies	O
,	O
were	O
sparse	O
(	O
Fig	O
.	O
2F	O
).	O

Tumors	B-DS
from	O
MMTV	B-OG
-	O
Wnt1	B-GP
mice	B-OG
displayed	O
bi	O
-	O
layered	O
papillary	O
arrays	O
of	O
cells	O
,	O
showed	O
an	O
equal	O
ratio	O
of	O
K14	B-GP
+/	O
K18	B-GP
+	O
cells	O
and	O
expressed	O
hormone	B-GP
receptors	I-GP
(	O
Fig	O
.	O
2G	O
–	O
I	O
).	O

They	O
showed	O
loss	O
of	O
polarized	O
organization	O
;	O
indicated	O
by	O
reduced	O
MUC1	B-GP
expression	O
(	O
Fig	O
.	O
2J	O
),	O
frequent	O
laminin	B-GP
V	I-GP
accumulation	O
in	O
patches	O
(	O
Fig	O
.	O
2K	O
),	O
and	O
stromal	O
hypertrophy	O
(	O
Fig	O
.	O
2L	O
).	O

In	O
conclusion	O
,	O
expression	O
of	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
induced	O
expansion	O
of	O
hormone	B-GP
-	I-GP
receptor	I-GP
-	O
negative	O
,	O
K18	B-GP
+	O
cells	O
,	O
which	O
maintained	O
alveolar	O
features	O
and	O
were	O
lactationally	O
competent	O
,	O
whereas	O
MMTV	B-OG
-	O
Wnt1	B-GP
expression	O
significantly	O
expanded	O
K14	B-GP
+	O
cells	O
in	O
addition	O
to	O
both	O
hormone	B-GP
-	I-GP
receptor	I-GP
-	O
positive	O
and	O
-	O
negative	O
K18	B-GP
+	O
cells	O
and	O
lead	O
to	O
perturbed	O
ductal	O
formation	O
and	O
lactational	O
failure	O
.	O

Phenotypic	O
differences	O
between	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
and	O
MMTV	B-OG
-	O
Wnt1	B-GP
hyperplasias	O
.	O

Mammary	O
glands	O
from	O
12	O
week	O
-	O
old	O
virgin	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
(	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
cat	O
)	O
(	O
A	O
–	O
E	O
)	O
and	O
MMTV	B-OG
-	O
Wnt1	B-GP
(	O
F	O
–	O
J	O
)	O
mice	B-OG
.	O

Mammary	O
whole	O
mounts	O
stained	O
with	O
carmine	O
(	O
A	O
,	O
F	O
)	O
or	O
X	O
-	O
Gal	O
(	O
C	O
,	O
D	O
,	O
H	O
,	O
I	O
).	O

Sections	O
stained	O
immunohistochemically	O
with	O
anti	O
-	O
K14	B-GP
antibodies	O
to	O
detect	O
the	O
basal	O
cells	O
(	O
B	O
,	O
G	O
)	O
or	O
with	O
X	O
-	O
Gal	O
to	O
detect	O
luminal	O
LTBP1	B-GP
-	O
lacZ	B-GP
expression	O
and	O
nuclear	O
fast	O
red	O
(	O
E	O
,	O
J	O
).	O

Note	O
mammary	O
glands	O
from	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
mice	B-OG
show	O
alveolar	O
hyperplasia	O
(	O
A	O
,	O
B	O
)	O
but	O
their	O
ductal	O
system	O
(	O
C	O
,	O
E	O
)	O
is	O
comparable	O
to	O
controls	O
(	O
D	O
).	O

Mammary	O
glands	O
from	O
MMTV	B-OG
-	O
Wnt1	B-GP
mice	B-OG
show	O
hyperbranching	O
(	O
F	O
),	O
K14	B-GP
+	O
cell	O
ensheathment	O
(	O
G	O
),	O
ductal	O
constriction	O
(	O
arrows	O
H	O
,	O
J	O
)	O
and	O
large	O
ductal	O
cysts	O
(	O
arrows	O
F	O
,	O
I	O
).	O

MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
and	O
MMTV	B-OG
-	O
Wnt1	B-GP
tumors	B-DS
have	O
distinct	O
cellular	O
composition	O
.	O

Tumor	B-DS
sections	O
from	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
(	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
cat	O
)	O
(	O
A	O
–	O
F	O
)	O
and	O
MMTV	B-OG
-	O
Wnt1	B-GP
(	O
G	O
–	O
L	O
)	O
stained	O
with	O
antibodies	O
as	O
indicated	O
against	O
K14	B-GP
,	O
K18	B-GP
,	O
estrogen	B-GP
receptor	I-GP
(	O
ER	B-GP
),	O
MUC1	B-GP
,	O
laminin	B-GP
,	O
and	O
vimentin	B-GP
.	O

Note	O
distorted	O
laminin	B-GP
deposition	O
(	O
Arrows	O
in	O
K	O
)	O
and	O
stromal	O
hyperplasia	O
(	O
L	O
).	O

MMTV	B-OG
-	O
Wnt1	B-GP
and	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
activate	O
the	O
canonical	O
signaling	O
pathway	O
within	O
different	O
cell	O
-	O
types	O

Based	O
on	O
the	O
disparate	O
phenotypes	O
described	O
above	O
,	O
we	O
hypothesized	O
that	O
ΔN89β	O
-	O
catenin	O
and	O
Wnt1	B-GP
transform	O
different	O
progenitors	O
.	O

The	O
MMTV	B-OG
-	O
LTR	O
is	O
expressed	O
within	O
mammary	O
luminal	O
epithelium	O
.	O

Therefore	O
β	B-GP
-	I-GP
catenin	I-GP
'	O
s	O
transcriptional	O
effects	O
are	O
restricted	O
to	O
cells	O
within	O
this	O
layer	O
,	O
whereas	O
Wnt1	B-GP
,	O
a	O
secreted	O
factor	O
,	O
can	O
act	O
in	O
an	O
autocrine	O
and	O
/	O
or	O
paracrine	O
fashion	O
in	O
any	O
cells	O
that	O
expresses	O
a	O
Wnt1	B-GP
receptor	I-GP
.	O

To	O
determine	O
which	O
cell	O
-	O
types	O
respond	O
to	O
the	O
expression	O
of	O
these	O
transgenes	O
via	O
activation	O
of	O
the	O
canonical	O
pathway	O
,	O
we	O
crossed	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
and	O
MMTV	B-OG
-	O
Wnt1	B-GP
mice	B-OG
to	O
Axin2	B-GP
-	O
d2EGFP	O
transgenic	O
and	O
Conductin	B-GP
+/	O
lz	O
heterozygous	O
lacZ	B-GP
knock	O
-	O
in	O
reporter	O
lines	O
.	O

The	O
Axin2	B-GP
/	O
Conductin	B-GP
gene	O
is	O
expressed	O
constitutively	O
in	O
response	O
to	O
canonical	O
Wnt	B-GP
/	O
β	B-GP
-	I-GP
catenin	I-GP
signaling	O
and	O
its	O
product	O
negatively	O
regulates	O
the	O
pathway	O
[	O
32	O
],	O
[	O
33	O
].	O

Despite	O
uniform	O
expression	O
of	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
within	O
the	O
luminal	O
epithelium	O
[	O
13	O
],	O
transcriptional	O
response	O
,	O
detected	O
by	O
Conductin	B-GP
-	O
lacZ	B-GP
reporter	O
expression	O
,	O
was	O
restricted	O
to	O
a	O
subpopulation	O
of	O
luminal	O
cells	O
scattered	O
along	O
secondary	O
and	O
tertiary	O
ducts	O
(	O
Fig	O
.	O
3A	O
).	O

In	O
early	O
hyperplasia	O
,	O
approximately	O
one	O
luminal	O
cell	O
per	O
alveolus	O
expressed	O
Conductin	B-GP
-	O
lacZ	B-GP
(	O
Fig	O
.	O
3B	O
)	O
and	O
these	O
cells	O
became	O
more	O
prominent	O
as	O
the	O
hyperplasia	O
increased	O
but	O
the	O
main	O
ducts	O
remained	O
devoid	O
of	O
β	B-GP
-	I-GP
catenin	I-GP
signaling	O
(	O
Fig	O
.	O
3C	O
).	O

In	O
contrast	O
,	O
mammary	O
glands	O
from	O
MMTV	B-OG
-	O
Wnt1	B-GP
mice	B-OG
showed	O
a	O
strikingly	O
uniform	O
Conductin	B-GP
-	O
lacZ	B-GP
expression	O
pattern	O
along	O
the	O
entire	O
mammary	O
ductal	O
system	O
(	O
Fig	O
.	O
3D	O
and	O
F	O
)	O
and	O
the	O
reporter	O
was	O
found	O
exclusively	O
within	O
basal	O
cells	O
(	O
Fig	O
.	O
3E	O
).	O

These	O
distinct	O
cellular	O
patterns	O
of	O
transcriptional	O
response	O
were	O
maintained	O
in	O
tumors	B-DS
(	O
Fig	O
.	O
4A	O
–	O
F	O
).	O

In	O
tumors	B-DS
from	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
mice	B-OG
,	O
Conductin	B-GP
-	O
lacZ	B-GP
was	O
expressed	O
within	O
cells	O
expressing	O
the	O
luminal	O
marker	O
K18	B-GP
and	O
absent	O
from	O
K14	B-GP
+	O
cells	O
(	O
Fig	O
.	O
4A	O
–	O
C	O
).	O

Wnt1	B-GP
tumors	B-DS
showed	O
the	O
converse	O
expression	O
pattern	O
;	O
Conductin	B-GP
-	O
lacZ	B-GP
expressing	O
cells	O
were	O
restricted	O
to	O
a	O
single	O
K14	B-GP
+/	O
K18	B-GP
−	O
layer	O
of	O
the	O
bilayered	O
papillary	B-DS
tumors	I-DS
(	O
Fig	O
.	O
4D	O
–	O
F	O
).	O

In	O
conclusion	O
,	O
these	O
data	O
show	O
that	O
a	O
subset	O
of	O
K18	B-GP
+	O
cells	O
respond	O
to	O
ΔN89β	O
-	O
catenin	O
.	O

K18	B-GP
+	O
luminal	O
epithelial	O
cells	O
from	O
MMTV	B-OG
-	O
Wnt1	B-GP
mice	B-OG
fail	O
to	O
respond	O
,	O
suggesting	O
they	O
lack	O
a	O
Wnt1	B-GP
receptor	I-GP
,	O
or	O
that	O
autocrine	O
canonical	O
pathway	O
activity	O
is	O
suppressed	O
by	O
non	O
-	O
canonical	O
antagonism	O
within	O
this	O
cell	O
-	O
type	O
.	O

In	O
contrast	O
,	O
K14	B-GP
+	O
cells	O
show	O
a	O
robust	O
paracrine	O
canonical	O
response	O
to	O
Wnt1	B-GP
.	O

Conductin	B-GP
-	O
lacZ	B-GP
is	O
expressed	O
in	O
K18	B-GP
+	O
subpopulations	O
in	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
and	O
K14	B-GP
+	O
subpopulations	O
in	O
MMTV	B-OG
-	O
Wnt1	B-GP
hyperplasia	O
.	O

Canonical	O
signaling	O
is	O
activated	O
in	O
disparate	O
cell	O
-	O
types	O
.	O

Sections	O
of	O
hyperplastic	O
glands	O
from	O
(	O
A	O
–	O
C	O
)	O
Conductin	B-GP
+/	O
lz	O
/	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
mice	B-OG
,	O
and	O
(	O
D	O
–	O
F	O
)	O
Conductin	B-GP
+/	O
lz	O
/	O
MMTV	B-OG
-	O
Wnt1	B-GP
mice	B-OG
stained	O
with	O
X	O
-	O
gal	O
to	O
detect	O
Conductin	B-GP
-	O
lacZ	B-GP
expression	O
(	O
blue	O
),	O
a	O
reporter	O
of	O
canonical	O
Wnt	B-GP
signaling	O
,	O
and	O
stained	O
with	O
antibodies	O
against	O
K14	B-GP
and	O
K18	B-GP
(	O
brown	O
)	O
as	O
indicated	O
.	O

Note	O
the	O
stromal	O
hypertrophy	O
surrounding	O
Wnt1	B-GP
hyperplastic	O
ducts	O
(	O
E	O
).	O

Conductin	B-GP
-	O
lacZ	B-GP
is	O
expressed	O
in	O
K18	B-GP
+	O
subpopulations	O
in	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
and	O
K14	B-GP
+	O
subpopulations	O
in	O
MMTV	B-OG
-	O
Wnt1	B-GP
tumors	B-DS
.	O

Sections	O
of	O
tumors	B-DS
from	O
(	O
A	O
–	O
C	O
)	O
Conductin	B-GP
+/	O
lacZ	B-GP
/	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
,	O
and	O
(	O
D	O
–	O
F	O
)	O
Conductin	B-GP
+/	O
lacZ	B-GP
/	O
MMTV	B-OG
-	O
Wnt1	B-GP
mice	B-OG
stained	O
with	O
X	O
-	O
gal	O
to	O
detect	O
Conductin	B-GP
-	O
lacZ	B-GP
expression	O
(	O
blue	O
),	O
a	O
reporter	O
of	O
canonical	O
Wnt	B-GP
signaling	O
,	O
and	O
stained	O
immunohistochemically	O
with	O
antibodies	O
against	O
K14	B-GP
and	O
K18	B-GP
(	O
brown	O
)	O
as	O
indicated	O
.	O

MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
and	O
MMTV	B-OG
-	O
Wnt1	B-GP
amplify	O
cells	O
with	O
distinct	O
CD24	B-GP
/	O
49f	O
stem	O
/	O
progenitor	O
profiles	O

To	O
further	O
compare	O
the	O
cell	O
-	O
type	O
composition	O
of	O
tumors	B-DS
,	O
we	O
isolated	O
mammary	O
epithelial	O
cells	O
(	O
MECs	O
)	O
from	O
tumors	B-DS
of	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
and	O
MMTV	B-OG
-	O
Wnt1	B-GP
mice	B-OG
and	O
investigated	O
their	O
expression	O
of	O
CD24	B-GP
and	O
CD49f	B-GP
.	O

These	O
markers	O
separate	O
MECs	O
from	O
wt	O
mice	B-OG
into	O
two	O
roughly	O
equal	O
populations	O
by	O
flow	O
cytometry	O
:	O
CD24highCD49flow	O
and	O
CD24lowCD49fhigh	O
(	O
Fig	O
.	O
5G	O
).	O

The	O
most	O
rightward	O
and	O
upward	O
shifted	O
cells	O
within	O
each	O
of	O
these	O
populations	O
have	O
been	O
reported	O
to	O
be	O
enriched	O
in	O
colony	O
-	O
forming	O
cell	O
(	O
CFC	O
)	O
comprising	O
alveolar	O
progenitors	O
and	O
multipotent	O
mammary	O
repopulating	O
units	O
(	O
MRUs	O
),	O
respectively	O
[	O
27	O
].	O
ΔN89β	O
-	O
catenin	O
tumors	B-DS
were	O
enriched	O
for	O
CD24highCD49flow	O
MECs	O
(	O
Fig	O
.	O
5A	O
)	O
(	O
62	O
%	O
compared	O
to	O
37	O
%	O
CD24lowCD49fhigh	O
).	O

In	O
contrast	O
,	O
Wnt1	B-GP
tumors	B-DS
were	O
enriched	O
for	O
CD24lowCD49fhigh	O
MECs	O
(	O
Fig	O
.	O
5D	O
)	O
(	O
65	O
%,	O
compared	O
to	O
35	O
%	O
CD24highCD49flow	O
).	O

To	O
characterize	O
cells	O
undergoing	O
an	O
active	O
transcriptional	O
response	O
to	O
expression	O
of	O
these	O
transgenes	O
,	O
we	O
crossed	O
MMTV	B-OG
-	O
Wnt1	B-GP
and	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
lines	O
to	O
the	O
Axin2	B-GP
-	O
d2EGFP	B-GP
reporter	I-GP
mouse	B-OG
,	O
isolated	O
tumor	B-DS
MECs	O
from	O
the	O
bitransgenic	O
progeny	O
and	O
analyzed	O
them	O
for	O
enhanced	B-GP
green	I-GP
fluorescent	I-GP
protein	I-GP
(	O
EGFP	B-GP
)	O
and	O
CD24	B-GP
/	O
CD49f	B-GP
expression	O
by	O
flow	O
cytometry	O
.	O

In	O
contrast	O
to	O
the	O
even	O
distribution	O
of	O
EGFP	B-GP
−	O
cells	O
from	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
mice	B-OG
between	O
the	O
two	O
major	O
CD24	B-GP
/	O
CD49f	B-GP
cell	O
populations	O
(	O
Fig	O
.	O
5B	O
),	O
cells	O
expressing	O
high	O
levels	O
of	O
EGFPhi	O
(	O
top	O
15	O
%)	O
(	O
Fig	O
.	O
5C	O
)	O
fell	O
exclusively	O
within	O
the	O
CD24highCD49flow	O
subpopulation	O
and	O
showed	O
an	O
upward	O
rightward	O
shift	O
in	O
mean	O
fluorescence	O
intensity	O
,	O
suggestive	O
of	O
CFCs	O
.	O

To	O
test	O
the	O
functional	O
significance	O
of	O
these	O
observations	O
,	O
we	O
compared	O
the	O
ability	O
of	O
EGFP	B-GP
+,	O
EGFP	B-GP
−	O
and	O
total	O
MECs	O
from	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
mice	B-OG
to	O
form	O
colonies	O
at	O
limiting	O
dilution	O
.	O

EGFP	B-GP
+	O
cells	O
showed	O
3	O
-	O
5	O
-	O
fold	O
greater	O
colony	O
forming	O
efficiency	O
compared	O
to	O
total	O
sorted	O
cells	O
,	O
and	O
a	O
corresponding	O
depletion	O
of	O
colony	O
-	O
forming	O
efficiency	O
was	O
found	O
within	O
the	O
EGFP	B-GP
−	O
cell	O
population	O
(	O
Fig	O
.	O
5H	O
).	O

Immunofluorescence	O
analysis	O
showed	O
that	O
EGFP	B-GP
+	O
cells	O
produced	O
colonies	O
composed	O
of	O
mixed	O
progeny	O
,	O
with	O
some	O
cells	O
expressing	O
K8	B-GP
and	O
others	O
K14	B-GP
(	O
Fig	O
.	O
5I	O
).	O

We	O
conclude	O
that	O
ΔN89β	O
-	O
catenin	O
signaling	O
cells	O
within	O
tumors	B-DS
show	O
marker	O
expression	O
profiles	O
that	O
mirror	O
those	O
of	O
CFC	O
alveolar	O
progenitors	O
from	O
normal	O
gland	O
and	O
are	O
bipotent	O
,	O
giving	O
rise	O
to	O
luminal	O
and	O
basal	O
cell	O
types	O
in	O
vitro	O
.	O

In	O
contrast	O
,	O
EGFP	B-GP
−	O
(	O
Fig	O
5E	O
)	O
and	O
EGFPhi	O
(	O
Fig	O
.	O
5F	O
)	O
cells	O
from	O
MMTV	B-OG
-	O
Wnt1	B-GP
mice	B-OG
were	O
distributed	O
in	O
both	O
CD24	B-GP
/	O
CD49f	B-GP
subpopulations	O
.	O

However	O
,	O
the	O
EGFPhi	O
(	O
Fig	O
.	O
5F	O
)	O
cells	O
were	O
skewed	O
to	O
the	O
right	O
side	O
of	O
the	O
CD24highCD49flow	O
population	O
and	O
those	O
within	O
the	O
CD24lowCD49fhigh	O
subpopulation	O
showed	O
an	O
upward	O
rightward	O
shift	O
.	O

These	O
shifts	O
are	O
consistent	O
with	O
the	O
profiles	O
of	O
CD61	B-GP
+/	O
K14	B-GP
+	O
progenitors	O
and	O
of	O
MRUs	O
that	O
have	O
been	O
shown	O
in	O
previous	O
reports	O
to	O
have	O
CSC	O
capabilities	O
[	O
22	O
],	O
[	O
27	O
],	O
[	O
28	O
],	O
[	O
34	O
].	O

MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
and	O
MMTV	B-OG
-	O
Wnt1	B-GP
tumors	B-DS
show	O
expansion	O
of	O
distinct	O
CD24	B-GP
/	O
CD49f	B-GP
cell	O
populations	O
.	O

CD24	B-GP
/	O
CD49f	B-GP
marker	O
profile	O
of	O
(	O
A	O
)	O
total	O
,	O
(	O
B	O
)	O
EGFP	B-GP
-	O
and	O
(	O
C	O
)	O
EGFPhi	O
cells	O
from	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
tumors	B-DS
.	O

Note	O
the	O
enrichment	O
and	O
upward	O
shift	O
of	O
EGFPhi	O
cells	O
within	O
the	O
CD24high	O
/	O
CD49flow	O
subpopulation	O
.	O

CD24	B-GP
/	O
CD49f	B-GP
marker	O
profile	O
of	O
(	O
D	O
)	O
total	O
,	O
(	O
E	O
)	O
EGFP	B-GP
-	O
and	O
(	O
F	O
)	O
EGFPhi	O
cells	O
from	O
MMTV	B-OG
-	O
Wnt1	B-GP
tumors	B-DS
.	O

Note	O
EGFPhi	O
cells	O
are	O
shifted	O
rightward	O
within	O
the	O
CD24high	O
/	O
CD49flow	O
subpopulation	O
and	O
upward	O
within	O
the	O
CD24low	O
/	O
CD49fhigh	O
subpopulation	O
.	O

CD24	B-GP
/	O
CD49f	B-GP
marker	O
profile	O
of	O
(	O
G	O
)	O
total	O
cells	O
from	O
a	O
wt	O
littermate	O
.	O

(	O
H	O
)	O
EGFP	B-GP
+	O
cells	O
from	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
tumors	B-DS
show	O
higher	O
colony	O
forming	O
efficiency	O
than	O
EGFP	B-GP
(−)	O
and	O
total	O
sorted	O
cells	O
.	O

(	O
I	O
)	O
Immunofluorescence	O
analysis	O
shows	O
these	O
EGFP	B-GP
+	O
cells	O
are	O
generate	O
colonies	O
containing	O
K14	B-GP
+	O
and	O
K8	B-GP
+	O
cells	O
.	O

MMTV	B-OG
-	O
Wnt1	B-GP
expression	O
induces	O
Hh	B-GP
pathway	O
activation	O
within	O
the	O
tumor	B-DS

Wnt	B-GP
and	O
Hh	B-GP
pathways	O
are	O
frequently	O
coupled	O
in	O
the	O
cross	O
-	O
talk	O
between	O
stem	O
cells	O
and	O
their	O
stromal	O
niche	O
and	O
an	O
essential	O
linkage	O
between	O
these	O
pathways	O
has	O
been	O
documented	O
recently	O
in	O
basal	B-DS
cell	I-DS
skin	I-DS
cancer	I-DS
[	O
35	O
].	O

To	O
determine	O
if	O
the	O
Hh	B-GP
pathway	O
was	O
activated	O
in	O
hyperplasia	O
and	O
tumors	B-DS
of	O
MMTV	B-OG
-	O
Wnt1	B-GP
and	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
mice	B-OG
,	O
we	O
crossed	O
these	O
lines	O
to	O
Gli1	B-GP
+/	O
lz	O
reporter	O
mice	B-OG
.	O

Hh	B-GP
signals	O
are	O
transduced	O
by	O
members	O
of	O
the	O
Gli	B-GP
protein	O
family	O
,	O
(	O
Gli1	B-GP
-	O
3	O
).	O

Gli1	B-GP
is	O
both	O
a	O
transcriptional	O
target	O
gene	O
and	O
positive	O
amplifier	O
of	O
the	O
pathway	O
.	O

Its	O
expression	O
is	O
strictly	O
dependent	O
upon	O
Hh	B-GP
signaling	O
and	O
thus	O
provides	O
a	O
reliable	O
reporter	O
of	O
Hh	B-GP
pathway	O
activation	O
[	O
36	O
].	O

Hh	B-GP
pathway	O
activity	O
is	O
repressed	O
within	O
the	O
mammary	O
tree	O
of	O
non	O
-	O
transgenic	O
Gli1	B-GP
+/	O
lz	O
control	O
glands	O
and	O
Gli1	B-GP
-	O
lacZ	B-GP
reporter	O
expression	O
was	O
restricted	O
to	O
lymphatics	O
(	O
Fig	O
.	O
6A	O
)	O
[	O
37	O
].	O

Similarly	O
,	O
hyperplasia	O
and	O
tumors	B-DS
from	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
;	O
Gli1	B-GP
+/	O
lz	O
mice	B-OG
showed	O
no	O
evidence	O
of	O
Gli1	B-GP
-	O
lacZ	B-GP
expression	O
within	O
the	O
epithelial	O
and	O
stromal	O
compartments	O
(	O
Fig	O
.	O
6B	O
).	O

In	O
contrast	O
,	O
tumors	B-DS
derived	O
from	O
MMTV	B-OG
-	O
Wnt1	B-GP
;	O
Gli1	B-GP
+/	O
lz	O
mice	B-OG
showed	O
robust	O
Gli1	B-GP
-	O
lacZ	B-GP
expression	O
within	O
stromal	O
cells	O
and	O
a	O
minor	O
subset	O
of	O
basal	O
cell	O
-	O
types	O
,	O
some	O
of	O
which	O
expressed	O
p63	B-GP
(	O
Fig	O
.	O
6C	O
,	O
D	O
).	O

Importantly	O
,	O
this	O
reporter	O
expression	O
was	O
restricted	O
to	O
the	O
tumor	B-DS
bed	O
and	O
not	O
observed	O
in	O
hyperplasia	O
(	O
Fig	O
.	O
6E	O
).	O

These	O
data	O
demonstrate	O
that	O
Wnt1	B-GP
expression	O
leads	O
to	O
aberrant	O
Hh	B-GP
pathway	O
activation	O
within	O
the	O
Wnt1	B-GP
tumor	B-DS
microenvironment	O
.	O

Hh	B-GP
pathway	O
activity	O
within	O
the	O
MMVT	O
-	O
Wnt1	B-GP
tumor	B-DS
microenvironment	O
.	O

Gli1	B-GP
-	O
lacZ	B-GP
expression	O
is	O
restricted	O
to	O
lymphatic	O
vessels	O
(	O
arrow	O
)	O
in	O
mammary	O
whole	O
mounts	O
of	O
(	O
A	O
)	O
control	O
Gli1	B-GP
+/	O
lz	O
mice	B-OG
,	O
and	O
absent	O
from	O
tumor	B-DS
sections	O
from	O
(	O
B	O
)	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
;	O
Gli1	B-GP
+/	O
lz	O
mice	B-OG
,	O
but	O
is	O
strongly	O
expressed	O
in	O
(	O
C	O
)	O
MMTV	B-OG
-	O
Wnt1	B-GP
;	O
Gli1	B-GP
+/	O
lz	O
tumor	B-DS
whole	O
mounts	O
.	O

In	O
sections	O
of	O
MMTV	B-OG
-	O
Wnt1	B-GP
;	O
Gli1	B-GP
+/	O
lz	O
tumors	B-DS
(	O
D	O
)	O
Gli1	B-GP
-	O
lacZ	B-GP
expression	O
is	O
found	O
within	O
stromal	O
cells	O
and	O
occasional	O
p63	B-GP
+	O
cells	O
(	O
arrow	O
).	O

(	O
E	O
)	O
Hyperplastic	O
MMTV	B-OG
-	O
Wnt1	B-GP
;	O
Gli1	B-GP
+/	O
lz	O
mammary	O
whole	O
mounts	O
from	O
12	O
week	O
-	O
old	O
mice	B-OG
show	O
lack	O
of	O
reporter	O
expression	O
within	O
unstained	O
mammary	O
hyperplasia	O
and	O
restriction	O
to	O
lymphatics	O
and	O
melanocytic	O
hyperplasia	O
(	O
boxed	O
area	O
).	O

MMTV	B-OG
-	O
Wnt1	B-GP
expression	O
results	O
in	O
dramatic	O
accumulation	O
and	O
differentiation	O
of	O
melanocytes	O
along	O
the	O
lactiferous	O
sinus	O
and	O
primary	O
ducts	O

Another	O
striking	O
linkage	O
between	O
Hh	B-GP
pathway	O
activation	O
and	O
MMTV	B-OG
-	O
Wnt1	B-GP
expression	O
was	O
found	O
in	O
melanocytic	O
hyperplasia	O
under	O
the	O
nipple	O
region	O
(	O
Fig	O
.	O
6E	O
box	O
).	O

A	O
hallmark	O
of	O
mammary	O
glands	O
from	O
pigmented	O
MMTV	B-OG
-	O
Wnt1	B-GP
mice	B-OG
was	O
accumulation	O
of	O
melanin	O
around	O
the	O
trunk	O
and	O
primary	O
mammary	O
branches	O
(	O
Fig	O
.	O
7A	O
,	O
E	O
).	O

Large	O
black	O
aggregates	O
emanating	O
from	O
the	O
nipple	O
mesenchyme	O
formed	O
spider	O
-	O
like	O
extensions	O
into	O
the	O
mammary	O
fat	O
-	O
pad	O
that	O
could	O
be	O
observed	O
by	O
eye	O
(	O
n	O
=	O
29	O
).	O

These	O
were	O
absent	O
from	O
mammary	O
glands	O
of	O
pigmented	O
wt	O
(	O
n	O
=	O
17	O
)	O
and	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
(	O
n	O
=	O
5	O
)	O
mice	B-OG
and	O
from	O
all	O
albino	O
mice	B-OG
regardless	O
of	O
genotype	O
(	O
n	O
=	O
34	O
Wnt	B-GP
;	O
n	O
=	O
10	O
ΔN89β	O
-	O
catenin	O
;	O
n	O
=	O
13	O
wild	O
-	O
type	O
).	O

Mammary	O
whole	O
-	O
mounts	O
(	O
Fig	O
.	O
7A	O
)	O
and	O
sections	O
(	O
Fig	O
.	O
7B	O
–	O
C	O
)	O
from	O
pigmented	O
MMTV	B-OG
-	O
Wnt1	B-GP
mice	B-OG
revealed	O
melanin	O
deposition	O
within	O
the	O
basal	O
layer	O
,	O
stromal	O
cells	O
and	O
occasionally	O
within	O
the	O
secretions	O
of	O
the	O
primary	O
lactiferous	O
ducts	O
.	O

However	O
,	O
immunohistochemical	O
analysis	O
with	O
antibodies	O
against	O
the	O
S100β	B-GP
melanocyte	O
marker	O
revealed	O
large	O
numbers	O
of	O
dendritic	O
melanocytes	O
in	O
albino	O
as	O
well	O
as	O
pigmented	O
Wnt1	B-GP
mice	B-OG
(	O
Fig	O
.	O
7C	O
,	O
G	O
).	O

We	O
conclude	O
that	O
Wnt	B-GP
-	I-GP
1	I-GP
expression	O
leads	O
to	O
migration	O
,	O
accumulation	O
and	O
differentiation	O
of	O
melanocytes	O
along	O
the	O
primary	O
mammary	O
ducts	O
and	O
that	O
these	O
cells	O
are	O
not	O
present	O
in	O
MMTVΔN89β	O
-	O
catenin	O
and	O
wt	O
mice	B-OG
.	O

Melanocytic	O
hyperplasia	O
associated	O
with	O
Hh	B-GP
pathway	O
activity	O
is	O
a	O
hallmark	O
of	O
all	O
MMTV	B-OG
-	O
Wnt1	B-GP
mammary	O
glands	O
.	O

Mammary	O
whole	O
mount	O
and	O
sections	O
from	O
pigmented	O
MMTV	B-OG
-	O
Wnt1	B-GP
mice	B-OG
show	O
melanin	O
deposition	O
(	O
A	O
,	O
B	O
)	O
and	O
presence	O
of	O
melanocytes	O
(	O
C	O
)	O
detected	O
by	O
anti	O
-	O
S100β	B-GP
(	O
DAKO	O
#	O
Z0311	O
).	O

Whole	O
mounts	O
and	O
sections	O
from	O
albino	O
(	O
D	O
,	O
G	O
)	O
and	O
pigmented	O
(	O
E	O
)	O
MMTV	B-OG
-	O
Wnt1	B-GP
;	O
Gli1lz	B-GP
/+	O
mice	B-OG
show	O
Gli1	B-GP
-	O
lacZ	B-GP
expression	O
around	O
the	O
primary	O
ducts	O
localizing	O
with	O
melanin	O
(	O
E	O
).	O

Conductin	B-GP
-	O
lacZ	B-GP
expression	O
(	O
blue	O
)	O
does	O
not	O
colocalize	O
with	O
S100β	B-GP
+	O
(	O
brown	O
)	O
(	O
F	O
).	O

However	O
a	O
minor	O
subset	O
of	O
S100β	B-GP
+	O
melanocytes	O
(	O
brown	O
)	O
(	O
red	O
arrows	O
)	O
and	O
many	O
of	O
their	O
neighboring	O
stromal	O
cells	O
express	O
the	O
Gli1	B-GP
-	O
lacZ	B-GP
reporter	O
(	O
blue	O
)	O
(	O
G	O
).	O

To	O
investigate	O
whether	O
Wnt1	B-GP
induces	O
these	O
effects	O
on	O
melanocytes	O
through	O
canonical	O
signaling	O
and	O
/	O
or	O
involves	O
Hh	B-GP
pathway	O
activation	O
,	O
we	O
examined	O
whole	O
mounts	O
of	O
bitransgenic	O
MMTV	B-OG
-	O
Wnt1	B-GP
;	O
Conductin	B-GP
+/	O
lz	O
and	O
MMTV	B-OG
-	O
Wnt1	B-GP
;	O
Gli1	B-GP
+/	O
lz	O
mice	B-OG
for	O
reporter	O
expression	O
.	O

Conductin	B-GP
-	O
Gal	O
was	O
restricted	O
to	O
basal	O
cells	O
and	O
absent	O
from	O
the	O
underlying	O
stroma	O
where	O
melanocytes	O
reside	O
(	O
Fig	O
.	O
7F	O
).	O

In	O
contrast	O
,	O
prominent	O
Gli1	B-GP
-	O
lacZ	B-GP
reporter	O
expression	O
was	O
observed	O
exclusively	O
around	O
the	O
primary	O
ducts	O
of	O
all	O
MMTV	B-OG
-	O
Wnt1	B-GP
;	O
Gli1	B-GP
+/	O
lz	O
mice	B-OG
(	O
n	O
=	O
8	O
)	O
(	O
Fig	O
.	O
7D	O
,	O
E	O
),	O
colocalizing	O
with	O
the	O
melanotic	O
aggregates	O
of	O
pigmented	O
MMTV	B-OG
-	O
Wnt1	B-GP
;	O
Gli1	B-GP
+/	O
lz	O
mice	B-OG
(	O
n	O
=	O
4	O
)	O
(	O
Fig	O
.	O
7E	O
)	O
and	O
within	O
a	O
subset	O
melanocytes	O
identified	O
by	O
S100β	B-GP
staining	O
and	O
many	O
neighboring	O
fibroblasts	O
in	O
albino	O
MMTV	B-OG
-	O
Wnt1	B-GP
;	O
Gli1	B-GP
+/	O
lz	O
mice	B-OG
(	O
n	O
=	O
4	O
)	O
(	O
Fig	O
.	O
7D	O
,	O
G	O
).	O
Gli1	B-GP
-	O
lacZ	B-GP
expression	O
was	O
absent	O
from	O
corresponding	O
regions	O
of	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
;	O
Gli1	B-GP
+/	O
lz	O
(	O
n	O
=	O
4	O
)	O
and	O
control	O
Gli1	B-GP
+/	O
lz	O
(	O
n	O
=	O
2	O
)	O
glands	O
.	O

We	O
conclude	O
that	O
MMTV	B-OG
-	O
Wnt1	B-GP
expression	O
induces	O
aberrant	O
melanocyte	O
accumulation	O
and	O
differentiation	O
within	O
the	O
fatpad	O
and	O
this	O
event	O
does	O
not	O
involve	O
canonical	O
pathways	O
but	O
correlates	O
with	O
robust	O
Hh	B-GP
pathway	O
activity	O
within	O
the	O
stroma	O
and	O
a	O
minor	O
melanocyte	O
subpopulation	O
.	O

Discussion	O

The	O
key	O
findings	O
of	O
this	O
study	O
are	O
that	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
and	O
MMTV	B-OG
-	O
Wnt1	B-GP
induce	O
distinct	O
tumors	B-DS
,	O
activate	O
canonical	O
signaling	O
in	O
disparate	O
cell	O
-	O
types	O
,	O
and	O
MMTV	B-OG
-	O
Wnt1	B-GP
alone	O
results	O
in	O
focal	O
Hh	B-GP
pathway	O
activity	O
within	O
the	O
mammary	B-DS
tumor	I-DS
microenvironment	O
and	O
in	O
and	O
around	O
melanocytic	O
hyperplasia	O
.	O

MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
and	O
MMTV	B-OG
-	O
Wnt1	B-GP
induce	O
canonical	O
signaling	O
in	O
distinct	O
cell	O
-	O
types	O

Previous	O
studies	O
have	O
shown	O
that	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
and	O
MMTV	B-OG
-	O
Wnt1	B-GP
tumors	B-DS
express	O
primitive	O
cell	O
markers	O
and	O
are	O
enriched	O
in	O
cell	O
populations	O
with	O
stem	O
/	O
progenitor	O
features	O
[	O
19	O
]–[	O
21	O
],	O
[	O
34	O
].	O

Our	O
work	O
extends	O
these	O
findings	O
by	O
identifying	O
the	O
cell	O
-	O
types	O
that	O
undergo	O
a	O
canonical	O
response	O
to	O
transgene	O
expression	O
.	O

Despite	O
uniform	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
expression	O
within	O
the	O
luminal	O
epithelium	O
[	O
13	O
],	O
our	O
results	O
show	O
that	O
a	O
specific	O
subset	O
of	O
luminal	O
cells	O
express	O
the	O
transcriptional	O
reporter	O
,	O
Conductin	B-GP
-	O
lacZ	B-GP
.	O

These	O
β	B-GP
-	I-GP
catenin	I-GP
-	O
responsive	O
cells	O
display	O
a	O
hormone	B-GP
-	I-GP
receptor	I-GP
-	O
negative	O
[	O
38	O
],	O
K18	B-GP
+	O
CD24highCD49flow	O
profile	O
,	O
and	O
generate	O
colonies	O
containing	O
both	O
K8	B-GP
+	O
and	O
K14	B-GP
+	O
cells	O
.	O

Thus	O
,	O
they	O
exhibit	O
the	O
expected	O
location	O
,	O
molecular	O
profile	O
and	O
functional	O
bipotency	O
ascribed	O
to	O
alveolar	O
progenitor	O
populations	O
from	O
normal	O
mammary	O
glands	O
[	O
21	O
],	O
[	O
27	O
].	O

These	O
features	O
,	O
in	O
conjunction	O
with	O
the	O
overwhelmingly	O
alveolar	O
-	O
like	O
phenotype	O
of	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
hyperplasia	O
,	O
strongly	O
support	O
the	O
hypothesis	O
that	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
acinar	B-DS
tumors	I-DS
develop	O
from	O
expansion	O
of	O
alveolar	O
progenitors	O
,	O
or	O
by	O
skewing	O
the	O
lineage	O
of	O
a	O
bipotent	O
alveolar	O
/	O
ductal	O
progenitor	O
towards	O
an	O
alveolar	O
fate	O
.	O

This	O
concept	O
is	O
reminiscent	O
of	O
K14	B-GP
-	O
ΔN80β	O
-	O
catenin	O
effects	O
on	O
skin	O
appendage	O
fate	O
and	O
consistent	O
with	O
our	O
previous	O
findings	O
that	O
known	O
regulators	O
of	O
alveolar	O
progenitor	O
determination	O
,	O
expansion	O
and	O
differentiation	O
influence	O
the	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
-	O
phenotype	O
[	O
18	O
],	O
[	O
38	O
].	O

Many	O
studies	O
have	O
assumed	O
that	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
and	O
MMTV	B-OG
-	O
Wnt1	B-GP
exert	O
a	O
similar	O
tumorigenic	O
effect	O
and	O
have	O
studied	O
these	O
models	O
interchangeably	O
.	O

Where	O
phenotypic	O
differences	O
have	O
been	O
noted	O
Wnt1	B-GP
'	O
s	O
potential	O
to	O
activate	O
non	O
-	O
canonical	O
pathways	O
has	O
been	O
speculated	O
upon	O
but	O
not	O
experimentally	O
addressed	O
.	O

Our	O
results	O
show	O
that	O
one	O
definitive	O
source	O
of	O
disparity	O
between	O
these	O
models	O
lies	O
in	O
the	O
failure	O
of	O
Wnt1	B-GP
to	O
induce	O
autocrine	O
canonical	O
signaling	O
and	O
its	O
ability	O
instead	O
to	O
induce	O
a	O
robust	O
paracrine	O
canonical	O
response	O
within	O
a	O
basally	O
located	O
K14	B-GP
+	O
cell	O
population	O
.	O

Several	O
pieces	O
of	O
data	O
suggest	O
that	O
this	O
Wnt1	B-GP
-	O
responsive	O
K14	B-GP
+	O
cell	O
population	O
consists	O
of	O
a	O
stem	O
cell	O
or	O
early	O
bipotent	O
progenitor	O
population	O
.	O

First	O
,	O
the	O
EGFPhi	O
expressing	O
cells	O
within	O
the	O
CD24lowCD49high	O
subpopulation	O
is	O
skewed	O
towards	O
higher	O
CD49f	B-GP
expression	O
,	O
a	O
feature	O
associated	O
with	O
MRU	O
capacity	O
,	O
and	O
depleted	O
of	O
cells	O
with	O
lower	O
CD49f	B-GP
expression	O
,	O
a	O
feature	O
associated	O
with	O
mature	O
myoepithelial	O
populations	O
[	O
27	O
].	O

EGFPhi	O
responding	O
cells	O
that	O
segregate	O
into	O
the	O
CD24highCD49low	O
group	O
are	O
also	O
skewed	O
rightwards	O
and	O
express	O
K14	B-GP
,	O
a	O
profile	O
recently	O
ascribed	O
to	O
a	O
CD61	B-GP
+	O
bipotent	O
progenitor	O
population	O
shown	O
to	O
have	O
cancer	B-DS
stem	O
cell	O
properties	O
[	O
22	O
],	O
[	O
28	O
].	O

Second	O
,	O
luminal	O
and	O
basal	O
cell	O
-	O
types	O
from	O
MMTV	B-OG
-	O
Wnt1	B-GP
tumors	B-DS
share	O
common	O
genetic	O
changes	O
suggesting	O
that	O
the	O
cell	O
-	O
type	O
transformed	O
by	O
Wnt1	B-GP
is	O
a	O
progenitor	O
of	O
both	O
lineages	O
[	O
19	O
].	O

Third	O
,	O
Wnt1	B-GP
produces	O
ductal	O
defects	O
(	O
see	O
fig	O
1	O
)	O
in	O
addition	O
to	O
suppressing	O
alveolar	O
secretory	O
differentiation	O
[	O
39	O
].	O

Collectively	O
,	O
these	O
results	O
suggest	O
that	O
MMTV	B-OG
-	O
Wnt1	B-GP
induces	O
expansion	O
of	O
a	O
multipotent	O
basal	O
cell	O
-	O
type	O
that	O
precedes	O
commitment	O
to	O
the	O
ductal	O
/	O
alveolar	O
as	O
well	O
as	O
luminal	O
/	O
basal	O
lineages	O
.	O

Wnt1	B-GP
leads	O
to	O
Hh	B-GP
pathway	O
activity	O
in	O
melanocytic	O
hyperplasia	O
and	O
their	O
surrounding	O
stroma	O

A	O
further	O
source	O
of	O
disparity	O
between	O
the	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
and	O
MMTV	B-OG
-	O
Wnt1	B-GP
phenotypes	O
relates	O
to	O
the	O
ability	O
of	O
the	O
latter	O
to	O
affect	O
additional	O
surrounding	O
cell	O
-	O
types	O
.	O

Of	O
note	O
,	O
stromal	O
hyperplasia	O
(	O
see	O
Fig	O
.	O
2L	O
and	O
3E	O
)	O
is	O
prominent	O
within	O
the	O
early	O
hyperplastic	O
glands	O
and	O
tumors	B-DS
of	O
MMTV	B-OG
-	O
Wnt1	B-GP
mice	B-OG
but	O
is	O
absent	O
from	O
glands	O
and	O
tumors	B-DS
of	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
mice	B-OG
.	O

Another	O
striking	O
example	O
is	O
the	O
dramatic	O
effect	O
on	O
melanocyte	O
populations	O
.	O

Our	O
results	O
show	O
that	O
massive	O
melanotic	O
deposits	O
within	O
the	O
mammary	O
fatpad	O
are	O
a	O
hallmark	O
of	O
pigmented	O
MMTV	B-OG
-	O
Wnt1	B-GP
mice	B-OG
and	O
that	O
large	O
numbers	O
of	O
amelanotic	O
melanocyte	O
precursors	O
accumulate	O
around	O
the	O
primary	O
lactiferous	O
ducts	O
of	O
both	O
pigmented	O
and	O
albino	O
MMTV	B-OG
-	O
Wnt1	B-GP
animals	B-OG
.	O

Murine	O
melanocyte	O
precursors	O
normally	O
reside	O
in	O
the	O
hair	O
follicle	O
bulge	O
and	O
are	O
not	O
detected	O
in	O
the	O
mammary	O
fatpads	O
of	O
wt	O
or	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
mice	B-OG
.	O

Although	O
both	O
canonical	O
and	O
non	O
-	O
canonical	O
Wnt	B-GP
signaling	O
have	O
been	O
implicated	O
in	O
promoting	O
melanocyte	O
proliferation	O
,	O
migration	O
and	O
differentiation	O
at	O
other	O
body	O
sites	O
[	O
40	O
],	O
the	O
lack	O
of	O
Conductin	B-GP
-	O
lacZ	B-GP
reporter	O
expression	O
within	O
the	O
mammary	O
melanocytic	O
hyperplasia	O
strongly	O
favors	O
non	O
-	O
canonical	O
signaling	O
.	O

Intriguingly	O
,	O
our	O
results	O
show	O
a	O
tight	O
correlation	O
between	O
positive	O
Hh	B-GP
signaling	O
within	O
a	O
minor	O
melanocytic	O
subpopulation	O
and	O
their	O
surrounding	O
stromal	O
neighbors	O
and	O
the	O
massive	O
accumulation	O
of	O
mobilized	O
,	O
differentiating	O
melanocytes	O
in	O
MMTV	B-OG
-	O
Wnt1	B-GP
glands	O
.	O

Current	O
literature	O
highlights	O
a	O
dualistic	O
role	O
for	O
Hh	B-GP
signaling	O
in	O
melanocyte	O
biology	O
[	O
41	O
],	O
[	O
42	O
].	O

Gli3R	B-GP
repression	O
of	O
Hh	B-GP
signaling	O
is	O
essential	O
for	O
melanoblast	O
specification	O
at	O
certain	O
body	O
regions	O
during	O
development	O
.	O

However	O
,	O
consistent	O
with	O
our	O
suggestion	O
that	O
Hh	B-GP
pathway	O
activity	O
is	O
linked	O
to	O
melanocytic	O
hyperplasia	O
,	O
one	O
report	O
has	O
shown	O
that	O
positive	O
Hh	B-GP
signaling	O
is	O
a	O
critical	O
determinant	O
of	O
melanoma	B-DS
growth	O
and	O
metastasis	O
[	O
42	O
].	O

Importantly	O
,	O
our	O
observations	O
show	O
that	O
Wnt	B-GP
and	O
Hh	B-GP
pathway	O
activity	O
are	O
linked	O
in	O
the	O
induction	O
of	O
these	O
melanocytic	O
accumulations	O
and	O
suggest	O
that	O
these	O
pathways	O
may	O
contribute	O
to	O
pigmentary	O
changes	O
arising	O
close	O
to	O
the	O
nipple	O
in	O
association	O
with	O
an	O
underlying	O
breast	B-DS
carcinoma	I-DS
.	O

Wnt1	B-GP
leads	O
to	O
Hh	B-GP
pathway	O
activity	O
within	O
the	O
mammary	B-DS
tumor	I-DS
microenvironment	O

A	O
second	O
major	O
site	O
of	O
focal	O
Hh	B-GP
pathway	O
activity	O
is	O
found	O
within	O
MMTV	B-OG
-	O
Wnt1	B-GP
tumors	B-DS
.	O

Of	O
note	O
,	O
Hh	B-GP
pathway	O
activity	O
was	O
restricted	O
to	O
the	O
Wnt	B-GP
-	I-GP
1	I-GP
tumor	B-DS
microenvironment	O
and	O
was	O
not	O
observed	O
within	O
the	O
Wnt	B-GP
-	I-GP
1	I-GP
hyperplasia	O
and	O
thus	O
correlated	O
with	O
Wnt1	B-GP
tumor	B-DS
onset	O
.	O

Hh	B-GP
pathway	O
repression	O
is	O
essential	O
for	O
embryonic	O
mammary	O
development	O
and	O
repression	O
remains	O
critical	O
to	O
homeostasis	O
in	O
the	O
postnatal	O
gland	O
[	O
37	O
].	O

Pathway	O
activation	O
distorts	O
mammary	O
development	O
,	O
and	O
is	O
found	O
in	O
both	O
epithelial	O
and	O
stromal	O
compartments	O
of	O
human	B-OG
breast	B-DS
cancers	I-DS
[	O
37	O
],	O
[	O
43	O
]–[	O
46	O
].	O

Intriguingly	O
,	O
Gli1	B-GP
-	O
lacZ	B-GP
is	O
expressed	O
within	O
a	O
minor	O
subset	O
of	O
p63	B-GP
+	O
basal	O
cells	O
in	O
Wnt1	B-GP
tumors	B-DS
and	O
Ihh	B-GP
has	O
been	O
proposed	O
to	O
regulate	O
proliferation	O
of	O
progenitors	O
from	O
stem	O
cells	O
via	O
regulation	O
of	O
p63	B-GP
isoform	O
expression	O
and	O
to	O
promote	O
human	B-OG
mammosphere	O
formation	O
,	O
considered	O
to	O
be	O
a	O
surrogate	O
in	O
vitro	O
assay	O
of	O
stem	O
cell	O
proliferation	O
[	O
47	O
],	O
[	O
48	O
].	O

However	O
the	O
most	O
prominent	O
site	O
of	O
Hh	B-GP
pathway	O
activity	O
in	O
MMTV	B-OG
-	O
Wnt1	B-GP
mice	B-OG
occurs	O
in	O
stromal	O
cells	O
exclusively	O
within	O
the	O
tumor	B-DS
microenvironment	O
.	O

Whether	O
stromal	O
Hh	B-GP
pathway	O
activation	O
is	O
essential	O
for	O
breast	B-DS
tumor	I-DS
onset	O
remains	O
to	O
be	O
determined	O
.	O

However	O
,	O
the	O
importance	O
of	O
this	O
possibility	O
has	O
been	O
underscored	O
by	O
a	O
recent	O
study	O
showing	O
an	O
essential	O
role	O
for	O
stromal	O
Hh	B-GP
pathway	O
activity	O
in	O
supporting	O
tumor	B-DS
cell	O
growth	O
of	O
xenografted	O
pancreatic	O
and	O
colonic	O
human	B-OG
cancers	B-DS
and	O
cell	O
lines	O
[	O
49	O
].	O

Given	O
that	O
MMTV	B-OG
-	O
Wnt1	B-GP
tumors	B-DS
are	O
enriched	O
in	O
cells	O
with	O
stem	O
/	O
progenitor	O
characteristics	O
,	O
we	O
speculate	O
that	O
stromal	O
Hh	B-GP
pathway	O
activity	O
may	O
be	O
indicative	O
of	O
the	O
step	O
when	O
CSCs	O
co	O
-	O
opt	O
bystanders	O
to	O
become	O
complicit	O
in	O
tumor	B-DS
formation	O
by	O
forming	O
a	O
supportive	O
CSC	O
niche	O
.	O

Currently	O
the	O
relative	O
importance	O
of	O
Hh	B-GP
pathway	O
activity	O
within	O
epithelial	O
and	O
stromal	O
compartments	O
of	O
tumors	B-DS
is	O
a	O
matter	O
of	O
heated	O
debate	O
[	O
49	O
],	O
[	O
50	O
].	O

As	O
MMTV	B-OG
-	O
Wnt1	B-GP
tumors	B-DS
recapitulate	O
the	O
pattern	O
of	O
activity	O
reported	O
for	O
human	B-OG
breast	B-DS
tumors	I-DS
they	O
may	O
provide	O
as	O
a	O
useful	O
genetic	O
model	O
to	O
dissect	O
the	O
contribution	O
of	O
Hedgehog	B-GP
signaling	O
within	O
these	O
different	O
cell	O
types	O
to	O
tumor	B-DS
onset	O
and	O
progression	O
.	O

In	O
summary	O
our	O
data	O
show	O
that	O
Wnt1	B-GP
and	O
ΔN89β	O
-	O
catenin	O
generate	O
distinct	O
tumors	B-DS
at	O
least	O
in	O
part	O
through	O
activating	O
canonical	O
signaling	O
in	O
distinct	O
progenitors	O
and	O
through	O
Wnt	B-GP
-	O
specific	O
paracrine	O
effects	O
on	O
multiple	O
cell	O
-	O
types	O
.	O

Our	O
data	O
also	O
show	O
that	O
Wnt	B-GP
1	I-GP
expression	O
is	O
linked	O
with	O
focal	O
Hedgehog	B-GP
pathway	O
activation	O
in	O
melanocytic	B-DS
nevi	I-DS
and	O
mammary	B-DS
tumors	I-DS
.	O

These	O
data	O
suggest	O
Hh	B-GP
pathway	O
activity	O
and	O
pigmentary	O
changes	O
may	O
have	O
utility	O
as	O
indicators	O
of	O
breast	B-DS
tumor	I-DS
onset	O
induced	O
by	O
excess	O
or	O
unopposed	O
Wnt	B-GP
ligand	O
.	O

Materials	O
and	O
Methods	O

Ethics	O
Statement	O

Animal	B-OG
maintenance	O
and	O
experimental	O
procedures	O
were	O
in	O
accordance	O
with	O
the	O
NIH	O
Guidelines	O
for	O
Animal	O
Care	O
and	O
Use	O
and	O
were	O
approved	O
by	O
the	O
Institutional	O
Animal	O
Care	O
and	O
Use	O
Committee	O
of	O
New	O
York	O
University	O
Medical	O
School	O
.	O

Mice	B-OG

MMTV	B-OG
-	O
Wnt1	B-GP
and	O
MMTV	B-OG
-	O
ΔN89β	O
-	O
catenin	O
mice	B-OG
were	O
as	O
described	O
[	O
13	O
].	O

Axin2	B-GP
-	O
d2EGFP	O
,	O
Conductin	B-GP
+/	O
lz	O
,	O
Gli1	B-GP
+/	O
lz	O
,	O
Ltpb1L	B-GP
+/	O
lz	O
were	O
provided	O
by	O
Drs	O
.	O

Franke	O
Costantini	O
,	O
Columbia	O
University	O
,	O
Alexandra	O
Joyner	O
,	O
Sloan	O
Kettering	O
Institute	O
and	O
Velocigene	O
,	O
Regeneron	O
Pharmaceuticals	O
,	O
Inc	O
.	O
[	O
32	O
],	O
[	O
33	O
],	O
[	O
36	O
],	O
[	O
51	O
].	O

Mammary	O
Whole	O
Mount	O
Staining	O

To	O
detect	O
lacZ	B-GP
expression	O
,	O
mammary	O
glands	O
and	O
tumors	B-DS
were	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
(	O
PFA	O
)	O
in	O
1	O
×	O
phosphate	O
buffered	O
saline	O
(	O
PBS	O
)	O
(	O
PFA	O
;	O
Sigma	O
Aldrich	O
,	O
St	O
.	O
Louis	O
,	O
MO	O
)	O
for	O
1	O
h	O
,	O
washed	O
thrice	O
in	O
rinse	O
buffer	O
(	O
2	O
mM	O
MgCl2	O
,	O
0	O
.	O
1	O
%	O
sodium	O
deoxycholate	O
,	O
0	O
.	O
2	O
%	O
NP40	O
in	O
PBS	O
)	O
for	O
1	O
h	O
each	O
and	O
stained	O
overnight	O
at	O
room	O
temperature	O
in	O
X	O
-	O
gal	O
staining	O
solution	O
(	O
50	O
mg	O
/	O
ml	O
5	O
-	O
bromo	O
-	O
4	O
-	O
chloro	O
-	O
3	O
-	O
indolyl	O
-	O
β	O
-	O
D	O
-	O
galactopyranoside	O
in	O
rinse	O
buffer	O
containing	O
5	O
mM	O
potassium	O
ferricyanide	O
,	O
5	O
mM	O
potassium	O
ferrocyanide	O
)	O
(	O
Applichem	O
,	O
Cheshire	O
,	O
CT	O
).	O

After	O
staining	O
,	O
glands	O
and	O
tumors	B-DS
were	O
rinsed	O
in	O
1	O
×	O
PBS	O
,	O
post	O
-	O
fixed	O
in	O
4	O
%	O
PFA	O
overnight	O
and	O
processed	O
for	O
paraffin	O
embedding	O
.	O

The	O
tissues	O
were	O
sectioned	O
,	O
counterstained	O
with	O
Nuclear	O
Fast	O
Red	O
(	O
Polyscientific	O
,	O
Bay	O
Shore	O
,	O
NY	O
)	O
and	O
mounted	O
for	O
histological	O
analyses	O
.	O

For	O
whole	O
mount	O
analysis	O
,	O
X	O
-	O
gal	O
stained	O
mammary	O
glands	O
were	O
counterstained	O
with	O
carmine	O
,	O
cleared	O
and	O
mounted	O
as	O
described	O
http	O
://	O
mammary	O
.	O
nih	O
.	O
gov	O
/	O
tools	O
/.	O

Histology	O

Tissues	O
were	O
either	O
fixed	O
in	O
PFA	O
and	O
X	O
-	O
gal	O
stained	O
as	O
described	O
above	O
or	O
fixed	O
in	O
10	O
%	O
phosphate	O
buffered	O
formalin	O
overnight	O
,	O
then	O
processed	O
and	O
embedded	O
in	O
paraffin	O
.	O

4	O
µ	O
sections	O
were	O
deparaffinized	O
with	O
xylene	O
(	O
or	O
citrosolve	O
for	O
X	O
-	O
gal	O
stained	O
tissue	O
)	O
and	O
rehydrated	O
through	O
a	O
graded	O
series	O
of	O
ethanol	O
.	O

Citric	O
acid	O
antigen	O
retrieval	O
was	O
performed	O
for	O
all	O
antibodies	O
by	O
microwaving	O
in	O
6	O
.	O
53	O
mM	O
sodium	O
citrate	O
pH	O
6	O
.	O
0	O
for	O
30	O
min	O
at	O
1	O
.	O
21	O
kilowatts	O
.	O

Rabbit	B-OG
antibodies	O
against	O
K14	B-GP
(	O
cat	O
#	O
PRB155P	O
,	O
Covance	O
,	O
Berkeley	O
,	O
CA	O
)	O
(	O
1	O
∶	O
2000	O
),	O
MUC1	B-GP
(	O
1	O
∶	O
500	O
)	O
(	O
Abcam	O
),	O
laminin	B-GP
(	O
1	O
∶	O
100	O
)	O
(	O
Sigma	O
),	O
S	B-GP
-	I-GP
100β	I-GP
(	O
1	O
∶	O
4000	O
)(	O
Dako	O
#	O
Z0311	O
),	O
mouse	B-OG
antibodies	O
against	O
K18	B-GP
(	O
cat	O
#	O
61028	O
,	O
Progen	O
Biotechnik	O
,	O
Heidelberg	O
,	O
Germany	O
),	O
estrogen	B-GP
receptor	I-GP
(	O
1	O
∶	O
500	O
)	O
(	O
DAKO	O
,	O
Carpinteria	O
,	O
CA	O
),	O
and	O
guinea	B-OG
-	I-OG
pig	I-OG
anti	O
-	O
vimentin	B-GP
(	O
1	O
∶	O
1000	O
)(	O
Progen	O
)	O
were	O
detected	O
using	O
biotin	O
labeled	O
secondary	O
antibodies	O
(	O
Vector	O
Labs	O
,	O
Burlingame	O
,	O
CA	O
)	O
(	O
1	O
∶	O
1000	O
)	O
in	O
conjunction	O
with	O
streptavidin	B-GP
peroxidase	B-GP
(	O
Fisher	O
Scientific	O
,	O
Suwanne	O
,	O
GA	O
)	O
that	O
was	O
colorimetrically	O
detected	O
using	O
diaminobenzidine	O
(	O
cat	O
#	O
K3466	O
,	O
DakoCytomation	O
,	O
Carpinteria	O
,	O
CA	O
).	O

For	O
S	B-GP
-	I-GP
100β	I-GP
staining	O
,	O
sections	O
were	O
subjected	O
to	O
antigen	O
retrieval	O
with	O
0	O
.	O
1	O
%	O
trypsin	B-GP
(	O
Sigma	O
#	O
T0303	O
),	O
0	O
.	O
1	O
%	O
CaCl2	O
in	O
50	O
mM	O
Tris	O
-	O
HCl	O
,	O
pH	O
7	O
.	O
6	O
at	O
37	O
°	O
C	O
for	O
45	O
min	O
in	O
a	O
humidified	O
chamber	O
.	O

Slides	O
were	O
washed	O
continuously	O
under	O
running	O
tap	O
water	O
for	O
5	O
min	O
and	O
processed	O
for	O
immunohistochemistry	O
.	O

Azure	O
B	O
staining	O
was	O
performed	O
as	O
described	O
[	O
52	O
].	O

Mammary	O
Epithelial	O
Cell	O
Isolation	O
and	O
Flow	O
Cytometry	O

Mammary	O
glands	O
and	O
tumors	B-DS
were	O
minced	O
and	O
digested	O
for	O
6	O
–	O
7	O
h	O
at	O
37	O
°	O
C	O
in	O
EpiCult	O
-	O
B	O
Medium	O
supplemented	O
with	O
5	O
%	O
fetal	O
bovine	O
serum	O
(	O
FBS	O
)	O
containing	O
300	O
U	O
ml	O
−	O
1	O
collagenase	B-GP
and	O
100	O
U	O
ml	O
−	O
1	O
hyaluronidase	B-GP
.	O

Digests	O
were	O
pipetted	O
8	O
–	O
12	O
times	O
and	O
vortexed	O
for	O
5	O
seconds	O
every	O
hour	O
.	O

After	O
dissociation	O
,	O
cells	O
were	O
pelleted	O
at	O
350	O
×	O
g	O
for	O
5	O
min	O
and	O
resuspended	O
in	O
a	O
1	O
∶	O
4	O
mixture	O
of	O
Hanks	O
'	O
Balanced	O
Salt	O
Solution	O
containing	O
2	O
%	O
FBS	O
(	O
HF	O
)	O
and	O
ammonium	O
chloride	O
and	O
centrifuged	O
again	O
.	O

Cell	O
pellets	O
were	O
gently	O
dissociated	O
for	O
3	O
min	O
in	O
5	O
ml	O
of	O
pre	O
-	O
warmed	O
0	O
.	O
25	O
%	O
trypsin	B-GP
-	O
EDTA	O
.	O

10	O
ml	O
of	O
cold	O
HF	O
was	O
added	O
.	O

Cells	O
were	O
pelleted	O
by	O
centrifugation	O
and	O
resuspended	O
for	O
1	O
min	O
in	O
5	O
mg	O
ml	O
−	O
1	O
of	O
pre	O
-	O
warmed	O
dispase	B-GP
II	I-GP
containing	O
0	O
.	O
1	O
mg	O
ml	O
−	O
1	O
DNase	B-GP
I	I-GP
,	O
then	O
diluted	O
with	O
10	O
ml	O
of	O
cold	O
HF	O
and	O
filtered	O
through	O
a	O
40	O
-	O
µm	O
mesh	O
.	O

All	O
reagents	O
were	O
from	O
StemCell	O
Technologies	O
Inc	O
.	O
[	O
27	O
].	O

All	O
antibodies	O
were	O
purchased	O
from	O
BD	O
Pharmingen	O
unless	O
otherwise	O
noted	O
.	O

Cells	O
at	O
a	O
concentration	O
of	O
2	O
.	O
5	O
×	O
106	O
per	O
100	O
µl	O
of	O
2	O
%	O
bovine	O
serum	O
albumin	B-GP
(	O
BSA	O
)	O
were	O
incubated	O
on	O
ice	O
for	O
30	O
min	O
with	O
primary	O
antibodies	O
:	O
0	O
.	O
5	O
ng	O
/	O
ml	O
of	O
biotinylated	O
TER119	B-GP
(	O
cat	O
#	O
553672	O
),	O
CD31	B-GP
(	O
cat	O
#	O
558737	O
),	O
CD45	B-GP
(	O
553078	O
),	O
CD24	B-GP
-	O
phycoerythrin	O
(	O
PE	O
)	O
(	O
cat	O
#	O
553262	O
),	O
and	O
0	O
.	O
25	O
ng	O
/	O
ml	O
of	O
CD49f	B-GP
-	O
allophycocyanin	B-GP
(	O
APC	B-GP
)	O
(	O
cat	O
#	O
FAB13501A	O
,	O
Minneapolis	O
,	O
MN	O
,	O
R	O
&	O
D	O
Systems	O
).	O

Cells	O
were	O
washed	O
once	O
in	O
200	O
µl	O
2	O
%	O
BSA	O
,	O
stained	O
with	O
1	O
.	O
5	O
ng	O
/	O
ml	O
of	O
streptavidin	B-GP
-	O
Alexa488	O
on	O
ice	O
for	O
30	O
min	O
,	O
washed	O
again	O
and	O
resuspended	O
in	O
2	O
%	O
BSA	O
.	O

1	O
µg	O
/	O
ml	O
of	O
7	O
-	O
aminoactinomycin	O
D	O
(	O
7	O
-	O
AAD	O
)	O
(	O
cat	O
#	O
00	O
-	O
6993	O
-	O
50	O
,	O
San	O
Diego	O
,	O
CA	O
,	O
eBioscience	O
)	O
was	O
added	O
just	O
prior	O
to	O
data	O
acquisition	O
.	O

Flow	O
cytometric	O
data	O
was	O
acquired	O
on	O
a	O
FACS	O
Caliber	O
cytometer	O
at	O
the	O
NYU	O
Skirball	O
FACS	O
Core	O
Facility	O
and	O
analyzed	O
using	O
FlowJo	O
software	O
[	O
27	O
]	O

Colony	O
-	O
Forming	O
Assays	O

NIH	O
-	O
3T3	O
cells	O
were	O
irradiated	O
in	O
suspension	O
at	O
20Gy	O
and	O
seeded	O
as	O
a	O
feeder	O
layer	O
24	O
h	O
prior	O
to	O
assay	O
,	O
at	O
a	O
concentration	O
of	O
1	O
.	O
9	O
×	O
104	O
cells	O
/	O
well	O
in	O
24	O
-	O
well	O
plates	O
(	O
Corning	O
Incorporated	O
,	O
Corning	O
,	O
NY	O
).	O

Lineage	O
+	O
cells	O
were	O
depleted	O
prior	O
to	O
sorting	O
using	O
the	O
EasySep	O
Cell	O
Biotin	O
Selection	O
Kit	O
(	O
StemCell	O
Technologies	O
Inc	O
.)	O
using	O
TER119	B-GP
,	O
CD31	B-GP
,	O
and	O
CD45	B-GP
and	O
CD140A	B-GP
(	O
eBioscience	O
)	O
antibodies	O
.	O

GFP	B-GP
+,	O
GFP	B-GP
−	O
and	O
Total	O
Sorted	O
tumor	B-DS
cells	O
were	O
sorted	O
into	O
1	O
ml	O
of	O
100	O
%	O
FBS	O
using	O
a	O
MoFlo	O
cell	O
sorter	O
,	O
excluding	O
cell	O
debris	O
,	O
cell	O
doublets	O
,	O
and	O
autofluorescent	O
cells	O
.	O

Sorted	O
cell	O
populations	O
were	O
centrifuged	O
at	O
350	O
g	O
for	O
3	O
mins	O
,	O
resuspended	O
in	O
a	O
300	O
µl	O
,	O
assessed	O
for	O
viability	O
in	O
50	O
%	O
Trypan	O
Blue	O
and	O
plated	O
at	O
limiting	O
dilution	O
.	O

Media	O
(	O
EpiCultB	O
+	O
bullet	O
,	O
5	O
%	O
FBS	O
,	O
100	O
U	O
/	O
ml	O
Penicillin	O
/	O
Streptomycin	O
,	O
1	O
µg	O
/	O
ml	O
Ciprofloxacin	O
,	O
0	O
.	O
25	O
µg	O
/	O
ml	O
Fungizone	O
)	O
was	O
changed	O
48	O
h	O
later	O
to	O
medium	O
lacking	O
FBS	O
.	O

Colonies	O
were	O
fixed	O
after	O
6	O
days	O
in	O
50	O
∶	O
50	O
acetone	O
∶	O
methanol	O
at	O
−	O
20	O
°	O
C	O
for	O
3	O
min	O
and	O
counted	O
.	O

Cells	O
were	O
stained	O
with	O
primary	O
antibodies	O
to	O
K8	B-GP
(	O
Progen	O
Cat	O
#	O
65138	O
)	O
and	O
K14	B-GP
(	O
1	O
∶	O
2	O
,	O
000	O
,	O
Covance	O
PRB	O
-	O
155P	O
)	O
for	O
30	O
min	O
,	O
washed	O
three	O
times	O
in	O
PBS	O
,	O
stained	O
with	O
goat	B-OG
anti	O
-	O
mouse	B-OG
(	O
1	O
∶	O
100	O
,	O
Invitrogen	O
Cat	O
#	O
A11801	O
)	O
and	O
donkey	B-OG
anti	O
-	O
rabbit	B-OG
(	O
1	O
∶	O
100	O
,	O
Chemicon	O
Cat	O
#	O
AP182C	O
)	O
followed	O
by	O
three	O
washes	O
in	O
PBS	O
.	O

Competing	O
Interests	O
:	O
The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

